All of the following are true except about GLP - 1 analogues except?
As GLP - 1 analogues are peptides and they should be given subcutaneously.
They stimulate β - cells and chronic use can lead to acute pancreatitis.
Liraglutide & Semaglutide can cause retinopathy.
Exenatide is nephrotoxic and contraindicated in renal failure.
All drug have to be given subcutaneously
Exenatide is safe in renal failure
They can lead to acute pancreatitis.
Liraglutide can lead to retinopathy